Showing results (971-980 of 1,286) with videos related to

Sort By:
Pageof 129
Journal of Cardiovascular Pharmacology and Therapeutics|April 22, 2015
Urinary Trypsin Inhibitor Reduced Inflammation Response Induced by HyperlipidemiaYing Deng, Junying Kong
Journal of Cardiovascular Pharmacology and Therapeutics|May 31, 2015
Erythropoietin Reverses Sepsis-Induced Vasoplegia to Norepinephrine Through Preservation of α1D-Adrenoceptor mRNA Expression and Inhibition of GRK2-Mediated Desensitization in Mouse AortaKannan Kandasamy, Soumen Choudhury, Vishakha Singh, et al.
Journal of Cardiovascular Pharmacology and Therapeutics|March 6, 2018
Cardiovascular Safety of the Selective μ-Opioid Receptor Antagonist Naloxegol: A Novel Therapy for Opioid-Induced ConstipationWilliam B White, Peter Kowey, Ulysses Diva, et al.
Journal of Cardiovascular Pharmacology and Therapeutics|December 20, 2018
Do We Need Potent Intravenous Antiplatelet Inhibition at the Time of Reperfusion During ST-Segment Elevation Myocardial Infarction?Joseph Allencherril, Mahboob Alam, Glenn Levine, et al.
Journal of Cardiovascular Pharmacology and Therapeutics|October 24, 2006
Dose-dependent effects of oral dronedarone on the circadian variation of RR and QT intervals in healthy subjects: implications for antiarrhythmic actionsNitin Wadhani, Jonnalagedda Sm Sarma, Bramah N Singh, et al.
Journal of Cardiovascular Pharmacology and Therapeutics|October 24, 2006
Variable response of conductance and resistance coronary arteries to endothelial stimulation in patients with heart failure due to nonischemic dilated cardiomyopathyFahed Bitar, Amir Lerman, Mohammed W Akhter, et al.
Journal of Cardiovascular Pharmacology and Therapeutics|August 8, 2006
Statin-induced myopathy: the two faces of JanusRohit Arora, Max Liebo, Frank Maldonado
Journal of Cardiovascular Pharmacology and Therapeutics|August 8, 2006
Resistant hypertension: diagnosis and managementDimitris P Papadopoulos, Vasilios Papademetriou
Journal of Cardiovascular Pharmacology and Therapeutics|August 8, 2006
Lack of deleterious interaction between angiotensin receptor blockers and beta-blockers in the treatment of patients with heart failureCharles H Hennekens, Magda Kowalczykowski, Danielle Hollar
Pageof 129